Merck KGaA (MKGAF)
151.92
-5.44
(-3.46%)
USD |
OTCM |
Sep 15, 16:00
Merck Price to Book Value : 1.915 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 1.915 |
| September 14, 2026 | 1.983 |
| September 11, 2026 | 1.944 |
| September 10, 2026 | 1.915 |
| September 09, 2026 | 1.982 |
| September 08, 2026 | 1.954 |
| September 04, 2026 | 2.006 |
| September 03, 2026 | 2.100 |
| September 02, 2026 | 2.063 |
| September 01, 2026 | 2.123 |
| August 31, 2026 | 2.042 |
| August 28, 2026 | 2.068 |
| August 27, 2026 | 1.993 |
| August 26, 2026 | 2.074 |
| August 25, 2026 | 2.067 |
| August 24, 2026 | 2.060 |
| August 21, 2026 | 2.057 |
| August 20, 2026 | 2.043 |
| August 19, 2026 | 2.061 |
| August 18, 2026 | 2.019 |
| August 17, 2026 | 1.995 |
| August 14, 2026 | 1.999 |
| August 13, 2026 | 2.048 |
| August 12, 2026 | 2.061 |
| August 11, 2026 | 2.061 |
| Date | Value |
|---|---|
| August 10, 2026 | 2.097 |
| August 07, 2026 | 2.115 |
| August 06, 2026 | 2.117 |
| August 05, 2026 | 2.139 |
| August 04, 2026 | 2.150 |
| August 03, 2026 | 2.080 |
| July 31, 2026 | 2.129 |
| July 30, 2026 | 2.132 |
| July 29, 2026 | 2.095 |
| July 28, 2026 | 2.111 |
| July 27, 2026 | 2.057 |
| July 24, 2026 | 2.016 |
| July 23, 2026 | 2.018 |
| July 22, 2026 | 1.942 |
| July 21, 2026 | 1.950 |
| July 20, 2026 | 2.003 |
| July 17, 2026 | 1.998 |
| July 16, 2026 | 1.953 |
| July 15, 2026 | 2.029 |
| July 14, 2026 | 2.014 |
| July 13, 2026 | 2.026 |
| July 10, 2026 | 2.069 |
| July 09, 2026 | 2.032 |
| July 08, 2026 | 2.035 |
| July 07, 2026 | 2.106 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| STRATEC SE | 6.600 |
| Sartorius AG | 5.879 |
| Petros Pharmaceuticals, Inc. | 0.2902 |
| Danaher Corp. | 2.799 |
| Illumina, Inc. | 11.83 |
Price to Book Value Related Metrics
| PE Ratio | 23.88 |
| PS Ratio | 2.680 |
| Price to Free Cash Flow | 837.20 |
| Price | 151.92 |
| Earnings Yield | 4.19% |
| Market Cap | 66.05B |
| Operating PE Ratio | 13.61 |
| Normalized PE Ratio | 20.25 |